Skip to main content

Advertisement

Log in

Elevated Serum PTH Is Independently Associated with Poor Outcomes in Older Patients with Hip Fracture and Vitamin D Inadequacy

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

To determine whether serum 25(OH)D and/or PTH levels in older patients with hip fracture (HF) could predict short-term clinical outcomes, we conducted a prospective observational study of 287 consecutive HF patients (mean age 81.9 ± 7.5 [SD] years, 72% females). The prevalence of vitamin D inadequacy (25[OH]D < 80 nmol/l) was 97.1%, that of vitamin D deficiency (25[OH]D < 50 nmol/l) was 79.8%, and that of elevated PTH level (>6.8 pmol/l) was 35.5%. After adjustment for age and sex, PTH was significantly associated with in-hospital mortality (OR = 1.12, 95% CI 10.5–1.20, P < 0.001), myocardial injury (OR = 1.05, 95% CI 1.03–1.15, P = 0.002), prolonged length of stay (LOS ≥ 20 days; OR = 1.05, 95% CI 1.01–1.06, P = 0.044), and being discharged to institutional care (OR = 1.07, 95% CI 1.01–1.18, P = 0.48). Secondary hyperparathyroidism (SHPT), but not vitamin D deficiency, was associated with older age, a higher prevalence of trochanteric fracture, coronary artery disease, hypertension, previous stroke, renal impairment, increased levels of serum osteocalcin, bone-specific alkaline phosphatase, and adiponectin as well as a significantly higher in-hospital mortality (11.8 vs. 0.54%, P = 0.001), perioperative myocardial injury (32.7 vs. 22.5%, P = 0.043), LOS ≥ 20 days (40.2 vs. 26.9%, P = 0.017), and being discharged to institutional care (29.5 vs. 14.6%, P = 0.019). In multivariate regression analyses, SHPT was strongly associated with in-hospital mortality and LOS ≥ 20 days. We conclude that elevated PTH (but not vitamin D deficiency per se) is a strong independent predictor of poor outcomes in older patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Aharonoff GB, Koval KJ, Skovron ML, Zuckerman JD (1997) Hip fractures in the elderly: predictors of one year mortality. J Orthop Trauma 11:162–165

    Article  PubMed  CAS  Google Scholar 

  2. Cree M, Soskolne CL, Belseck E, Hornig J, McElhaney JE, Brant R, Suarez-Almazor M (2000) Mortality and institutionalization following hip fracture. J Am Geriatr Soc 48:283–288

    PubMed  CAS  Google Scholar 

  3. Gruson KI, Aharonoff GB, Egol KA, Zuckerman JD, Koval KJ (2002) The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma 16:39–44

    Article  PubMed  Google Scholar 

  4. Elliott J, Beringer T, Kee F, Marsh D, Willis C, Stevenson M (2003) Predicting survival after treatment for fracture of the proximal femur and the effect of delays to surgery. J Clin Epidemiol 56:788–795

    Article  PubMed  CAS  Google Scholar 

  5. Franzo A, Francescutti C, Simon G (2005) Risk factors correlated with post-operative mortality for hip fracture surgery in the elderly: a population-based approach. Eur J Epidemiol 20:985–991

    Article  PubMed  Google Scholar 

  6. Robbins JA, Biggs ML, Cauley J (2006) Adjusted mortality after hip fracture: from the cardiovascular health study. J Am Geriatr Soc 54:1885–1891

    Article  PubMed  Google Scholar 

  7. Holt G, Smith R, Duncan K, Finlayson DF, Gregori A (2008) Early mortality after surgical fixation of hip fractures in the elderly: an analysis of data from the Scottish hip fracture audit. J Bone Joint Surg Br 90:1357–1363

    Article  PubMed  CAS  Google Scholar 

  8. Mizrahi EH, Fleissig Y, Arad M, Blumstein T, Adunsky A (2007) Admission albumin levels and functional outcome of elderly hip fracture patients: is it that important? Aging Clin Exp Res 19:284–289

    PubMed  CAS  Google Scholar 

  9. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501

    Article  PubMed  CAS  Google Scholar 

  10. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35:312–319

    Article  PubMed  CAS  Google Scholar 

  11. Saquib N, von Muhlen D, Garland CF, Barrett-Connor E (2006) Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study. Osteoporos Int 17:1734–1741

    Article  PubMed  CAS  Google Scholar 

  12. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P (2009) Vitamin D status, parathyroid function, bone turnover and bone mineral density in postmenopausal women with osteoporosis in global perspective. J Bone Miner Res 24:693–701

    Article  PubMed  CAS  Google Scholar 

  13. Sahota O, Gaynor K, Harwood RH, Hosking DJ (2001) Hypovitaminosis D and “functional hypoparathyroidism”—the NoNoF (Nottingham neck of Femur) study. Age Ageing 30:467–472

    Article  PubMed  CAS  Google Scholar 

  14. Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, Pioli G (2006) High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest 29:809–813

    PubMed  CAS  Google Scholar 

  15. Fisher AA, Southcott EK, Srikusalanukul W, Davis MW, Hickman PE, Potter JM, Smith PN (2007) Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci 37:222–232

    PubMed  CAS  Google Scholar 

  16. Bischoff-Ferrari HA, Can U, Staehelin HB, Platz A, Henschkowski J, Michel BA, Dawson-Hughes B, Theiler R (2008) Severe vitamin D deficiency in Swiss hip fracture patients. Bone 42:597–602

    Article  PubMed  CAS  Google Scholar 

  17. Sambrook PN, Chen JS, March LM, Cameron ID, Cumming RG, Lord SR, Schwarz J, Seibel MJ (2004) Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxyvitamin D status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 89:5477–5481

    Article  PubMed  CAS  Google Scholar 

  18. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281

    Article  PubMed  CAS  Google Scholar 

  19. Bjorkman MP, Sorva AJ, Tilvis RS (2008) Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur J Endocrinol 158:749–753

    Article  PubMed  CAS  Google Scholar 

  20. Chen JS, Sambrook PN, March L, Cameron ID, Cumming RG, Simpson JM, Seibel MJ (2008) Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf) 68:290–298

    CAS  Google Scholar 

  21. Melamed ML, Michos ED, Post W, Astor B (2008) 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629–1637

    Article  PubMed  Google Scholar 

  22. Shardell M, Hicks GE, Miller RR, Kritchevsky S, Andersen D, Bandinelli S, Cherubini A, Ferrucci L (2009) Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci 64:69–75

    PubMed  Google Scholar 

  23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470

    PubMed  CAS  Google Scholar 

  24. Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A, Cormier C (2003) The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab 88:3501–3504

    Article  PubMed  CAS  Google Scholar 

  25. Carlstedt F, Lind L, Wide L, Lindahl B, Hanni A, Rastad J, Ljunghall S (1997) Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest 27:977–981

    Article  PubMed  CAS  Google Scholar 

  26. Carlstedt F, Lind L, Rastad J, Stjernstrom H, Wide L, Ljunghall S (1998) Parathyroid hormone and ionized calcium levels are related to the severity of illness and survival in critically ill patients. Eur J Clin Invest 28:898–903

    Article  PubMed  CAS  Google Scholar 

  27. Lind L, Carlstedt F, Rastad J, Stiernstrom H, Stridsberg M, Ljunggren O, Wide L, Larsson A, Hellman P, Ljunghall S (2000) Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med 28:93–99

    Article  PubMed  CAS  Google Scholar 

  28. Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR (2008) Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study. Nephrol Dial Transplant 23:1650–1658

    Article  PubMed  CAS  Google Scholar 

  29. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52:519–530

    Article  PubMed  CAS  Google Scholar 

  30. Hedback G, Oden A (1998) Increased risk of death from primary hyperparathyroidism—an update. Eur J Clin Invest 28:271–276

    Article  PubMed  CAS  Google Scholar 

  31. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O’Fallon WM, Melton LJ III (1998) Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 104:115–122

    Article  PubMed  CAS  Google Scholar 

  32. Nilsson IL, Wadsten C, Brandt L, Rastad J, Ekbom A (2004) Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery 136:981–987

    Article  PubMed  Google Scholar 

  33. Fisher AA, Southcott EN, Goh SL, Srikusalanukul W, Hickman PE, Davis MW, Potter JM, Budge MM, Smith PN (2008) Elevated serum cardiac troponin I in older patients with hip fracture: incidence and prognostic significance. Arch Orthop Trauma Surg 128:1073–1079

    Article  PubMed  CAS  Google Scholar 

  34. Sambrook PN, Chen CJ, March L, Cameron ID, Cumming RG, Lord SR, Simpson JM, Seibel MJ (2006) High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res 21:549–555

    Article  PubMed  Google Scholar 

  35. Fahrleitner-Pammer A, Herberth J, Browning SR, Obermayer-Pietsch B, Wirnsberger G, Holzer H, Dobnig H, Malluche HH (2008) Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res 23:1850–1858

    Article  PubMed  CAS  Google Scholar 

  36. Wannamethee SG, Whincup PH, Lennon L, Sattar N (2007) Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 167:1510–1517

    Article  PubMed  CAS  Google Scholar 

  37. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer CD, Snijder MB, Bouter LM, Matsuzawa Y, Shimomura I, Heine RJ (2008) Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 93:1489–1496

    Article  PubMed  CAS  Google Scholar 

  38. Lee SH, Ha JW, Kim JS, Choi EY, Park S, Kang SM, Choi D, Jang Y, Chung N (2009) Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry. Coron Artery Dis 20:33–39

    Article  PubMed  Google Scholar 

  39. Rejnmark L, Vestergaard P, Brot C, Mosekilde L (2008) Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics. Clin Endocrinol (Oxf) 69:29–35

    Article  CAS  Google Scholar 

  40. Patel S, Hyer S, Barron J (2007) Glomerular filtration rate is a major determinant of the relationship between 25-hydroxyvitamin D and parathyroid hormone. Calcif Tissue Int 80:221–226

    Article  PubMed  CAS  Google Scholar 

  41. Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA (2006) Calcium in cell injury and death. Annu Rev Pathol 1:405–434

    Article  PubMed  CAS  Google Scholar 

  42. Verkhratsky A (2007) Calcium and cell death. Subcell Biochem 45:465–480

    Article  PubMed  CAS  Google Scholar 

  43. Vieth R, Ladak Y, Walfish PG (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88:185–191

    Article  PubMed  CAS  Google Scholar 

  44. Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2009) Factors associated with elevated or blunted PTH response in vitamin D insufficient adults. J Intern Med 265:488–495

    Article  PubMed  CAS  Google Scholar 

  45. Silver J, Levi R (2005) Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin Nephrol 63:119–126

    PubMed  CAS  Google Scholar 

  46. Sahota O, Mundey MK, San P, Godber IM, Hosking DJ (2006) Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 17:1013–1021

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Fisher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fisher, A., Goh, S., Srikusalanukul, W. et al. Elevated Serum PTH Is Independently Associated with Poor Outcomes in Older Patients with Hip Fracture and Vitamin D Inadequacy. Calcif Tissue Int 85, 301–309 (2009). https://doi.org/10.1007/s00223-009-9283-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-009-9283-1

Keywords

Navigation